Erin M. Garvey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erin M. Garvey has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Amir M. Alhajjat
Division of Pediatric Surgery, Phoenix Children's Hospital, 1919 E Thomas Rd, Phoenix, AZ 85016
1 shared publicationBenjamin Padilla
Division of Pediatric Surgery Phoenix Children's Hospital Phoenix AZ
1 shared publicationCaitlin A. Smith
Univ Washington, Seattle Childrens Hosp, Dept Surg, Seattle, WA USA
1 shared publicationCasey M. Calkins
Medical College of Wisconsin, Children's Wisconsin, Milwaukee, WI
1 shared publicationCristine S. Velazco
Department of General Surgery, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ 85054
1 shared publicationDaniel J. Ostlie
Division of Pediatric Surgery, Phoenix Children's Hospital, 1919 E Thomas Rd, Phoenix, AZ 85016
1 shared publication
Latest Publications
- 17 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163084
Why some children die more often in crashes—and what surgeons can do to change this
- 17 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163084
Why some children die more often in crashes—and what surgeons can do to change this
- 12 September 2023
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 77 (6) , E93-E98
Expedited Laparoscopic Cholangiogram and Liver Biopsy in the Workup of Biliary Atresia
Purpose: Recent studies demonstrate the success of Kasai portoenterostomy for biliary atresia (BA) is linearly related to infant age at time of Kasai. We sought to review the feasibility and safety of laparoscopic needle micropuncture cholangiogram with concurrent core liver biopsy (if needed) for expedited exclusion of BA in patients with direct conjugated hyperbilirubinemia.Methods: Expedited laparoscopic cholangiogram and liver biopsy were instituted at our facility for infants with direct hyperbilirubinemia for whom clinical exam and laboratory workup failed to diagnose. A retrospective chart review was performed in infants <1 year with hyperbilirubinemia from 2016 to 2021. Demographics, preoperative evaluation, procedure details, and complications were reviewed.Results: Two hundred ninety‐seven infants with unspecified jaundice were identified, of which, 86 (29%) required liver biopsy. Forty‐seven percutaneous liver biopsies were obtained including 8 (17%) in whom BA could not be excluded. Laparoscopic cholangiogram was attempted in 47 infants following basic workup; BA was diagnosed in 22 infants (47%) of which 3 were <18 days old. Biliary patency was demonstrated laparoscopically in 22 of 25 (88%); 3 (12%) required conversion to open cholangiogram. Infants with percutaneous liver biopsy had an average delay of 3 days (range: 2–36) to cholangiogram. Preoperative studies and liver biopsy alone did not reliably exclude the diagnosis of BA.Conclusion: Laparoscopic cholangiogram with liver biopsy is a safe procedure resulting in the confirmation or exclusion of BA in infants. Forty‐seven percent of infants who underwent laparoscopic cholangiogram were found to have BA; those who were surgical candidates underwent Kasai during the same operation.
- 12 September 2023
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 77 (6) , E93-E98
Expedited Laparoscopic Cholangiogram and Liver Biopsy in the Workup of Biliary Atresia
Purpose: Recent studies demonstrate the success of Kasai portoenterostomy for biliary atresia (BA) is linearly related to infant age at time of Kasai. We sought to review the feasibility and safety of laparoscopic needle micropuncture cholangiogram with concurrent core liver biopsy (if needed) for expedited exclusion of BA in patients with direct conjugated hyperbilirubinemia.Methods: Expedited laparoscopic cholangiogram and liver biopsy were instituted at our facility for infants with direct hyperbilirubinemia for whom clinical exam and laboratory workup failed to diagnose. A retrospective chart review was performed in infants <1 year with hyperbilirubinemia from 2016 to 2021. Demographics, preoperative evaluation, procedure details, and complications were reviewed.Results: Two hundred ninety‐seven infants with unspecified jaundice were identified, of which, 86 (29%) required liver biopsy. Forty‐seven percutaneous liver biopsies were obtained including 8 (17%) in whom BA could not be excluded. Laparoscopic cholangiogram was attempted in 47 infants following basic workup; BA was diagnosed in 22 infants (47%) of which 3 were <18 days old. Biliary patency was demonstrated laparoscopically in 22 of 25 (88%); 3 (12%) required conversion to open cholangiogram. Infants with percutaneous liver biopsy had an average delay of 3 days (range: 2–36) to cholangiogram. Preoperative studies and liver biopsy alone did not reliably exclude the diagnosis of BA.Conclusion: Laparoscopic cholangiogram with liver biopsy is a safe procedure resulting in the confirmation or exclusion of BA in infants. Forty‐seven percent of infants who underwent laparoscopic cholangiogram were found to have BA; those who were surgical candidates underwent Kasai during the same operation.
- 13 February 2022
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 57 (6) , 1033-1039
Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery
- 13 February 2022
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 57 (6) , 1033-1039
Characterizing the use of botulinum toxin in patients with Hirschsprung disease treated at referral institutions for pediatric colorectal surgery
- 1 May 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (5) , 892-899
Mentorship in pediatric surgery: A need for structure?
- 1 May 2021
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 56 (5) , 892-899
Mentorship in pediatric surgery: A need for structure?